.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
UBS
Argus Health
Accenture
McKinsey
Merck
Cerilliant
Cantor Fitzgerald
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020235

« Back to Dashboard

NDA 020235 describes NEURONTIN, which is a drug marketed by Pfizer Pharms and Parke Davis and is included in three NDAs. It is available from four suppliers. There are two patents protecting this drug. Additional details are available on the NEURONTIN profile page.

The generic ingredient in NEURONTIN is gabapentin. There are twenty-eight drug master file entries for this compound. One hundred and eight suppliers are listed for this compound. Additional details are available on the gabapentin profile page.

Summary for 020235

Tradename:1
Applicant:1
Ingredient:1
Patents:1
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details

Pharmacology for NDA: 020235

Suppliers and Packaging for NDA: 020235

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEURONTIN gabapentin CAPSULE;ORAL 020235 NDA Parke-Davis Div of Pfizer Inc 0071-0803 0071-0803-24 100 CAPSULE in 1 BOTTLE (0071-0803-24)
NEURONTIN gabapentin CAPSULE;ORAL 020235 NDA Parke-Davis Div of Pfizer Inc 0071-0805 0071-0805-24 100 CAPSULE in 1 BOTTLE (0071-0805-24)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2017Product Flag?Substance Flag?Delist Request?Y

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2017Product Flag?Substance Flag?Delist Request?Y

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength400MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Oct 25, 2017Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 020235

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-003Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-001Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-003Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-001Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-003Dec 30, 1993► Subscribe► Subscribe
Pfizer PharmsNEURONTINgabapentinCAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Medtronic
UBS
Fuji
Deloitte
Farmers Insurance
Daiichi Sankyo
Moodys
Johnson and Johnson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot